Overview by Region (Quarter)

• Japan: The Company concentrated on enhancing sales activities which match each market; the acute care hospital market, the small and mid-sized hospital market, and the clinic market. The Company also focused on its consumables and services business as well as strengthening its marketing and service capabilities, creating customer value which contributed to improving medical safety, patient outcomes, and operating efficiency. As a result of these initiatives, sales in all markets and all product categories increased. Sales in the university and private hospital markets increased favorably thanks to large orders related to construction of new hospitals. Sales in the public hospital and clinic markets also increased.

 

• International:  Overseas sales showed double-digit growth due to yen depreciation and the impact of a change in the fiscal term of Defibtech, LLC according to the reorganization of subsidiaries in the U.S. In the Americas, sales in the U.S. and Latin America showed double-digit growth. In the U.S., sales of Treatment Equipment and Physiological Measuring Equipment increased significantly, while sales of Patient Monitors decreased. In Latin America, sales in Columbia and Mexico showed strong growth. Sales in Europe decreased on a local currency basis and increased on a yen basis. Sales in Germany decreased compared to the strong growth in the same period of the previous fiscal year, while sales in the U.K. and the Netherlands showed strong growth. In Asia & Other, sales increased, especially in Malaysia. A large order in Morocco also contributed to the sales increase. Sales growth moderated in China mainly due to the impact of the anti-corruption campaign from the third quarter of FY2023.

 

*Defibtech, LLC changed its fiscal term from end on December 31 to end on March 31, according to the reorganization of U.S. subsidiaries. In the nine months ended December 31, 2023, Nihon Kohden consolidated the 12 months of Defibtech’s operating results from January 1, 2023 to December 31, 2023.